Topic: Richard Burt
Adult stem cell studies abound for heart, diabetes, MS; far ahead of embryonic researchA few months ago, Dr. Thomas Einhorn was treating a patient with a broken ankle that wouldn't heal, even with multiple surgeries. So he sought help from the ...
A new stem cell therapy improved the symptoms of early-stage multiple sclerosis (MS) in 80 percent of patients enrolled in a small clinical trial published today in The Lancet Neurology.. In the case of MS, the patient's immune system destroys protein ...
In the case of type 1 diabetes, it destroys the insulin-producing cells in the pancreas, and in multiple sclerosis it strikes the central nervous system.. Burt, of Northwestern University, first imagined stem cell treatments 20 years ago, while working with leukemia patients ...
A controversial stem cell treatment tested in Brazil has freed patients with type-1 diabetes from dependence on insulin. Demonstrating that most patients had elevated blood concentrations of C-peptide, a breakdown product of insulin production, Burt says is a clear sign that the ...
Autologous non-myeloablative hemopoietic stem cell transplantation may prevent neurological progression and improve neurological disability in relapsing-remitting multiple sclerosis, according to research published online Jan. 30 in The Lancet Neurology.. Richard K. Burt, M.D., of the Northwestern University Feinberg School of Medicine ...
"This is the first trial for any phase of MS, whether early or later, of any therapy anywhere that has shown reversal of neurological disability," said study author Dr. Richard K. Burt, chief of the division of immunotherapy at the Northwestern University ...
For the first time, some of the disability associated with the early stages of multiple sclerosis appears to have been reversed. Clean slate Richard Burt of Northwestern University Feinberg School of Medicine in Chicago and his colleagues had previously tried using stem ...
"This is the first trial for any phase of MS, whether early or later, of any therapy anywhere that has shown reversal of neurological disability," said study author Dr. Richard K. Burt, chief of the division of immunotherapy at the Northwestern University ...
2/26/2008 Print E-mail Treatment with adult stem cells harvested from blood or bone marrow may benefit some patients with certain kinds of cardiovascular disorders and autoimmune diseases, a new U.S. analysis shows.. ". Dr. Richard K. Burt, of the Northwestern ...